Episode 042: Myeloma Series, Pt.3 - Intro to ...

This week, we are so excited to share the third episode of our Career Development Series episodes, developed in partnership with The American Society of Hematology, The ASH Trainee Council, and Hematopoiesis! For years, our listeners have reached out to our show asking for guidan ...  Show more

Throughout this series, we have discussed how multidisciplinary the management of head and neck cancer is and the critical role that our surgical colleagues play in the management of this disease. This week, we welcome Dr. Michael Topf, Associate Professor for Associate Professor ...  Show more

This week’s episode is part 2 of our plasma cell dyscrasias series. We will go over the important details on risk stratification, as well as initial and relapse treatment options for Multiple Myeloma, with key details on the pharmacology of myeloma drugs.

In this episode I cover myeloma.

If you want to follow along with written notes on myeloma go to zerotofinals.com/medicine/haematology/myeloma/ or the haematology section in the Zero to Finals medici ...

This episode is a continuation of the Hematology and Oncology chapter of Crush Step 1. Content covered includes: - Lymphomas - Histiocyte Disorders (Langerhans Cell Histiocytosis [LCH] and Histiocytosis X) - Plasma Cell Disorders (Multiple Myeloma, Waldenström Macroglobulinemia [ ...  Show more

Joseph Mikhael, MD, and Irene Ghobrial, MD, discuss screening high-risk populations for early-stage multiple myeloma and new techniques to detect it. Relevant disclosures can be found with the episode show notes on Medscape.com ( https://www.medscape.com/viewarticle/964336). The t ...  Show more